Cantargia competitorsClear all
Cantargia's top competitors include MetaStat, NeOnc Technologies, Sonnet BioTherapeutics and CARsgen Therapeutics.
| Save Comparison |  Cantargia Cantargia is a biotechnology company that specializes in the development of pharmaceuticals for various types of cancer, autoimmune and inflammatory diseases. |  MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs. |  NeOnc Technologies NeOnc Technologies is an early-stage cancer biotechnology company focused on intranasal inhalation of monoterpene. |  CARsgen Therapeutics CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment. | |
Founding Date | Founding Date 2010 | Founding Date 2010 | Founding Date 2008 | Founding Date 2011 | Founding Date 2014 |
Type | Type Public | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Lund, SE HQ | Locations Boston, US HQ | Locations West Hollywood, US HQ | Locations Princeton, US HQ | Locations Shanghai, CN HQ Beijing, CN Shanghai, CN Shanghai, CN Bellaire, US |
Employees | Employees 843% decrease | Employees 6 | Employees N/A | Employees 30 | Employees 403% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26 k | Valuation ($) N/A | Valuation ($) 47.4 m | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 341 | Twitter followers 4 | Twitter followers N/A | Twitter followers 39 |
Alexa Website Rank | Alexa Website Rank 281446 | Alexa Website Rank N/A | Alexa Website Rank 355077 | Alexa Website Rank 265217 | Alexa Website Rank 55264 |
Financial | |||||
Net income | Net income N/A | Net income ($3.2m) (FY, 2018) | Net income N/A | Net income ($24.3m) (FY, 2020) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 150k (over 8 years ago) | Latest funding round N/A | Latest funding round $ 186m (3 months ago) |
Total funding raised | Total funding raised $ 1m | Total funding raised $ 350k | Total funding raised N/A | Total funding raised $ 750k | Total funding raised $ 276m |
For sources of this data, please see the company profile
View company profiles
MetaStat
HQ
Boston, US
Employees
6
MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
View companyNeOnc Technologies
HQ
West Hollywood, US
NeOnc Technologies is an early-stage cancer biotechnology company focused on intranasal inhalation of monoterpene.
View company
Sonnet BioTherapeutics
HQ
Princeton, US
Employees
30
Sonnet BioTherapeutics is an oncology-focused biotechnology company.
View companyCARsgen Therapeutics
HQ
Shanghai, CN
Employees
40↑ 3% increase
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
View company